Anti-IL-6 / IFNb2 Reference Antibody (elsilimomab)
- Product Code: 140248
Molecular Weight: | Molecular Formula: | ||
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
Used in research and development for targeting interleukin-6 (IL-6) signaling pathways, this antibody has been explored in inflammatory and autoimmune conditions where IL-6 plays a key role. It has shown potential in modulating immune responses in diseases such as rheumatoid arthritis and cytokine release syndrome. Additionally, it has been investigated in oncology for its ability to interfere with IL-6-mediated tumor growth and survival signals. Its application remains primarily in preclinical and early clinical studies to understand disease mechanisms and therapeutic targeting.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-IL-6 / IFNb2 Reference Antibody (elsilimomab)
Used in research and development for targeting interleukin-6 (IL-6) signaling pathways, this antibody has been explored in inflammatory and autoimmune conditions where IL-6 plays a key role. It has shown potential in modulating immune responses in diseases such as rheumatoid arthritis and cytokine release syndrome. Additionally, it has been investigated in oncology for its ability to interfere with IL-6-mediated tumor growth and survival signals. Its application remains primarily in preclinical and early clinical studies to understand disease mechanisms and therapeutic targeting.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :